[HTML][HTML] Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha, AI Lamond - Molecular cell, 2013 - cell.com
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

Identification and functional characterization of FMN2: a regulator of the cyclin-dependent kinase Inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha… - Molecular …, 2013 - discovery.dundee.ac.uk
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

[PDF][PDF] Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha… - Molecular Cell, 2013 - researchgate.net
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha… - Molecular …, 2013 - pubmed.ncbi.nlm.nih.gov
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21.

K Yamada, M Ono, ND Perkins, S Rocha… - Molecular Cell, 2013 - europepmc.org
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

[HTML][HTML] Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha, AI Lamond - Molecular Cell, 2013 - Elsevier
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha… - Molecular Cell, 2013 - eprints.ncl.ac.uk
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

[PDF][PDF] Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha… - Molecular Cell, 2013 - cyberleninka.org
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha, AI Lamond - Molecular Cell, 2013 - infona.pl
The ARF tumor suppressor is a central component of the cellular defense against oncogene
activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting …

[引用][C] Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21

K Yamada, M Ono, ND Perkins, S Rocha, AI Lamond - Molecular Cell, 2013 - cir.nii.ac.jp
Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent
Kinase Inhibitor p21 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …